Somerville, NJ (PRWEB) January 14, 2009
Effectively and safely achieving glycemic goal has long been considered the "brass ring" in diabetes management but recent studies (ACCORD, ADVANCE and UKPDS-80) paint a more complex picture, showing that aggressive glycemic control in some cases is associated with a higher risk of cardiovascular disease.
A newly launched online, multi-media presentation by Anthony McCall, Professor of Diabetes at the University of Virginia, Charlottesville, offers a detailed view of the studies presented at the 68th Scientific Sessions of the American Diabetes Association. Dr. McCall addresses the question "how will these results affect the day-to-day practice of the healthcare provider?"
His slide and audio presentation, titled, "How Low Should You Go? Glycemic Control in T2DM: Discord over ADVANCE, ACCORD, and UKPDS-80" is now available online at the Diabetes Best Practices Website at Diabetes and Cardiovascular Disease Presentation
"It is my hope to empower health care providers to develop their own best practice strategies for treating patients who are at high risk for cardiovascular disease and diabetes-related comorbidities (eg, obesity, myocardial infarction, stroke) and who have other diabetes risk factors," explained Dr. McCall.
"Log on and listen, download the slides to present to others and join our blog to add your perspective, opinions, and feedback," says Dr. McCall. "The management of diabetes is constantly evolving and at the Community of Best Practices is a place where you can work with your colleagues to debate new developments and advance day-to-day practice," he added.
The Community of Best Practices (Diabetes Best Practices) is an innovative Web forum launched in January 2008. It is an interactive environment in which clinicians can discuss and share their best practices related to diabetes care and management. Clinicians may log on to watch audiovisual presentations by physician faculty, read and contribute to useful tips in the blog, and view a calendar of events and links to diabetes resources.
The Web Site is a collaborative project of the University of Medicine and Dentistry of New Jersey (UMDNJ) and Embryon and is supported by an educational grant from sanofi-aventis U.S.
The University of Medicine and Dentistry of New Jersey is the nation's largest health sciences university. UMDNJ-Center for Continuing and Outreach Education (UMDNJ-CCOE) is the university's accrediting unit sponsoring national and international continuing medical education for a wide range of healthcare professionals.
Embryon is a medical communications provider to the pharmaceutical industry